Skip to main content
FDA Shortage Check

Is Valproate Sodium Injection in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Valproate Sodium Injection: in shortage

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Demand increase for the drug”. FDA shortage reason (FDASIA), reported by the manufacturer
DRUG
Valproate Sodium Injection
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Dec 30, 2020
LAST FDA UPDATE
Oct 15, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 2 presentations: 1 unavailable · 0 limited · 1 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Valproate Sodium Injection. 2 presentations from 2 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Fresenius Kabi USA, LLC1 presentation · 1 unavailable

Contact (FDA's listing): 888-386-1300

  • 100 mg/1 mL

    Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05)

    Next release November 2026. Check wholesalers for inventory.

    NDC 63323-494-05Reverified

    Unavailable

Hikma Pharmaceuticals USA, Inc.1 presentation · 1 available or not stated

Contact (FDA's listing): 800-631-2174

  • 500 mg/5 mL

    Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10)

    Additional lots will be available. Product will be made available as it is released.

    NDC 0143-9785-10Reverified

    Available

What the manufacturers told FDA

  • Fresenius Kabi USA, LLC · ‘Next release November 2026. Check wholesalers for inventory.’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Demand increase for the drug

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Valproate Sodium Injection in shortage?
Yes. As of Oct 24, 2026, FDA lists Valproate Sodium Injection as currently in shortage: 2 presentations, 1 unavailable and 0 limited.
When will the Valproate Sodium Injection shortage end?
FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Valproate Sodium Injection?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.